long term semaglutide Long-term weight loss effects of in obesity without diabetes in the SELECT trial Study raises red flags over

It is approved by the Food and Drug Administration (FDA) for weight loss and long-term weight management in adults and adolescents 12 years and older with obesity, as well as adults who are overweight and have at least one weight-related health condition, such as high cholesterol or Type 2 diabetes

Bloomberg reports that Health Canada is currently reviewing nine generic semaglutide applications, including those from Sandoz Group and Reddys Laboratories, and that the regulator has told both companies their copycat versions do not yet meet requirements

Additionally, pairing medication with healthy eating, regular activity, and adequate sleep boosts results

Can you take semaglutide and tirzepatide together

Who Should Choose Semaglutide